Oxytocin inhibition of (Ca2+ + Mg2+)-ATPase activity in rat myometrial plasma membranes.
D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium / Q000378:metabolism; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors*; D002462:Cell Membrane / Q000201:enzymology; D004054:Diethylstilbestrol / Q000494:pharmacology; D004386:Duodenum / Q000201:enzymology; D004533:Egtazic Acid / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008861:Microsomes / Q000201:enzymology; D009215:Myometrium / Q000187:drug effects / Q000201:enzymology*; D009928:Organ Specificity; D010121:Oxytocin / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014599:Uterus / Q000201:enzymology*
D011374:Progesterone; D010121:Oxytocin; D004533:Egtazic Acid; D004054:Diethylstilbestrol; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002118:Calcium